Skip to main content

Related Topic: Liquid Crystals in Dermal and Transdermal Delivery

  • Chapter
  • First Online:
Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds
  • 1298 Accesses

Abstract

This chapter deals with liquid crystal-based formulations in dermal and transdermal skin delivery. An overview of microstructures, excipients, and characterization techniques is presented and followed by a review of the work done to date on the potential of liquid crystals as topical drug delivery systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schuetz YB, Naik A, Guy RH, Kalia YN (2005) Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv 2(3):533–548

    Article  CAS  PubMed  Google Scholar 

  2. Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D (2008) Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 5(7):737–755

    Article  CAS  PubMed  Google Scholar 

  3. Lapteva M, Kalia YN (2013) Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery. Expert Opin Drug Deliv 10(8):1043–1059

    Article  CAS  PubMed  Google Scholar 

  4. Ganem-Quintanar A, Quintanar-Guerrero D, Buri P (2000) Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 26(8):809–820

    Article  CAS  PubMed  Google Scholar 

  5. Guo C, Wang J, Cao F, Lee RJ, Zhai G (2010) Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 15(23–24):1032–1040

    Article  CAS  PubMed  Google Scholar 

  6. Tang TY, Brooks NJ, Jeworrek C, Ces O, Terrill NJ, Winter R, Templer RH, Seddon JM (2012) Hydrostatic pressure effects on the lamellar to gyroid cubic phase transition of monolinolein at limited hydration. Langmuir 28(36):13018–13024

    Article  CAS  PubMed  Google Scholar 

  7. Kulkarni CV (2011) Nanostructural studies on monoelaidin-water systems at low temperatures. Langmuir 27(19):11790–11800

    Article  CAS  PubMed  Google Scholar 

  8. Tenchov B, Koynova R, Rapp G (1998) Accelerated formation of cubic phases in phosphatidylethanolamine dispersions. Biophys J 75(2):853–866

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Takahashi H, Hatta I, Quinn PJ (1996) Cubic phases in hydrated 1:1 and 1:2 dipalmitoylphosphatidylcholine-dipalmitoylglycerol mixtures. Biophys J 70(3):1407–1411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chen Y, Ma P, Gui S (2014) Cubic and hexagonal liquid crystals as drug delivery systems. Biomed Res Int 2014:815981

    PubMed  PubMed Central  Google Scholar 

  11. Wadsten-Hindrichsen P, Bender J, Unga J, Engstrom S (2007) Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci 315(2):701–713

    Article  CAS  PubMed  Google Scholar 

  12. Bender J, Ericson MB, Merclin N, Iani V, Rosen A, Engstrom S, Moan J (2005) Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release 106(3):350–360

    Article  CAS  PubMed  Google Scholar 

  13. Bender J, Simonsson C, Smedh M, Engstrom S, Ericson MB (2008) Lipid cubic phases in topical drug delivery: visualization of skin distribution using two-photon microscopy. J Control Release 129(3):163–169

    Article  CAS  PubMed  Google Scholar 

  14. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C (2005) Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22(12):2163–2173

    Article  CAS  PubMed  Google Scholar 

  15. Merclin N, Bender J, Sparr E, Guy RH, Ehrsson H, Engstrom S (2004) Transdermal delivery from a lipid sponge phase—iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J Control Release 100(2):191–198

    Article  CAS  PubMed  Google Scholar 

  16. Cohen-Avrahami M, Aserin A, Garti N (2010) H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf B Biointerfaces 77(2):131–138

    Article  CAS  PubMed  Google Scholar 

  17. Cohen-Avrahami M, Libster D, Aserin A, Garti N (2011) Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery. J Phys Chem B 115(34):10189–10197

    Article  CAS  PubMed  Google Scholar 

  18. Cohen-Avrahami M, Libster D, Aserin A, Garti N (2012) Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac. J Control Release 59(3):419–428

    Article  Google Scholar 

  19. Han IH, Choi SU, Nam DY, Park YM, Kang MJ, Kang KH, Kim YM, Bae G, Oh IY, Park JH, Ye JS, Choi YB, Kim DK, Lee J, Choi YW (2010) Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Arch Pharm Res 33(2):293–299

    Article  CAS  PubMed  Google Scholar 

  20. Libster D, Aserin A, Garti N (2011) Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications. J Colloid Interface Sci 356(2):375–386

    Article  CAS  PubMed  Google Scholar 

  21. Lopes LB, Collett JH, Bentley MV (2005) Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm 60(1):25–30

    Article  CAS  PubMed  Google Scholar 

  22. Lopes LB, Ferreira DA, de Paula D, Garcia MT, Thomazini JA, Fantini MC, Bentley MV (2006) Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res 23(6):1332–1342

    Article  CAS  PubMed  Google Scholar 

  23. Lopes LB, Lopes JL, Oliveira DC, Thomazini JA, Garcia MT, Fantini MC, Collett JH, Bentley MV (2006) Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm 63(2):146–155

    Article  CAS  PubMed  Google Scholar 

  24. Lopes LB, Speretta FF, Bentley MV (2007) Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur J Pharm Sci 32(3):209–215

    Article  CAS  PubMed  Google Scholar 

  25. Yariv D, Efrat R, Libster D, Aserin A, Garti N (2010) In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids Surf B Biointerfaces 78(2):185–192

    Article  CAS  PubMed  Google Scholar 

  26. Kreilgaard M (2002) Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54(Suppl 1):S77–S98

    Article  CAS  PubMed  Google Scholar 

  27. Muller-Goymann CC (2004) Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58(2):343–356

    Article  CAS  PubMed  Google Scholar 

  28. Efrat R, Shalev DE, Hoffman RE, Aserin A, Garti N (2008) Effect of sodium diclofenac loads on mesophase components and structure. Langmuir 24(14):7590–7595

    Article  CAS  PubMed  Google Scholar 

  29. Hathout RM, Woodman TJ, Mansour S, Mortada ND, Geneidi AS, Guy RH (2010) Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40(3):188–196

    Article  CAS  PubMed  Google Scholar 

  30. Kogan A, Shalev DE, Raviv U, Aserin A, Garti N (2009) Formation and characterization of ordered bicontinuous microemulsions. J Phys Chem B 113(31):10669–10678

    Article  CAS  PubMed  Google Scholar 

  31. Kreilgaard M, Pedersen EJ, Jaroszewski JW (2000) NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release 69(3):421–433

    Article  CAS  PubMed  Google Scholar 

  32. Liu H, Wang Y, Lang Y, Yao H, Dong Y, Li S (2009) Bicontinuous cyclosporin a loaded water-AOT/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci 98(3):1167–1176

    Article  CAS  PubMed  Google Scholar 

  33. Naoui W, Bolzinger MA, Fenet B, Pelletier J, Valour JP, Kalfat R, Chevalier Y (2011) Microemulsion microstructure influences the skin delivery of an hydrophilic drug. Pharm Res 28(7):1683–1695

    Article  CAS  PubMed  Google Scholar 

  34. Shevachman M, Garti N, Shani A, Sintov AC (2008) Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev Ind Pharm 34(4):403–412

    Article  CAS  PubMed  Google Scholar 

  35. Garti N, Libster D, Aserin A (2012) Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives. Food Funct 3(7):700–713

    Article  CAS  PubMed  Google Scholar 

  36. Makai M, Csanyi E, Nemeth Z, Palinkas J, Eros I (2003) Structure and drug release of lamellar liquid crystals containing glycerol. Int J Pharm 256(1–2):95–107

    Article  CAS  PubMed  Google Scholar 

  37. Savic S, Weber C, Tamburic S, Savic M, Muller-Goymann C (2009) Topical vehicles based on natural surfactant/fatty alcohols mixed emulsifier: the influence of two polyols on the colloidal structure and in vitro/in vivo skin performance. J Pharm Sci 98(6):2073–2090

    Article  CAS  PubMed  Google Scholar 

  38. Muzzalupo R, Tavano L, Nicoletta FP, Trombino S, Cassano R, Picci N (2010) Liquid crystalline Pluronic 105 pharmacogels as drug delivery systems: preparation, characterization, and in vitro transdermal release. J Drug Target 18(5):404–411

    Article  CAS  PubMed  Google Scholar 

  39. Harris KD (2012) Powder diffraction crystallography of molecular solids. Top Curr Chem 315:133–177

    Article  CAS  PubMed  Google Scholar 

  40. Garg G, Saraf S (2007) Cubosomes: an overview. Biol Pharm Bull 30(2):350–353

    Article  CAS  PubMed  Google Scholar 

  41. Namdeo A, Jain N (2002) Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride. J Control Release 82(2–3):223–236

    Article  CAS  PubMed  Google Scholar 

  42. Hosmer JM, Steiner AA, Lopes LB (2013) Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride. Pharm Res 30(3):694–706

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yogeshvar N. Kalia .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Lapteva, M., Kalia, Y.N. (2017). Related Topic: Liquid Crystals in Dermal and Transdermal Delivery. In: Sugibayashi, K. (eds) Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56526-0_13

Download citation

Publish with us

Policies and ethics